DreaMed

📍 Petah Tikva, Israel🗓 Founded 2014👥 41 employees💰 Last funded Sep 2024
Hospitals and Health Care🌐 dreamed.ai
Website LinkedIn
Founded in 2014, our company pioneered the first artificial pancreas technology. Since then, DreaMed has dedicated itself to developing decision-support tools in the diabetes management field. We are the worlds first and only company to receive FDA clearance for a decision support system that utilizes data from CGM/SMBG (continuous glucose monitoring/self-monitoring of blood glucose) and insulin pumps. Our founders are all physicians and engineers. Our products are developed based on real insights from the clinical practice of diabetes specialists, physicians, and clinical researchers from the top diabetes centers worldwide. We prioritize privacy, security, quality, and regulatory compliance, operating under a stringent quality management system and adhering to ISO 27001, GDPR, and HIPAA standards. Additionally, our product FDA-cleared.
1
Total investors
0
Early stage
0
Mid stage
1
Late stage
2014
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Israel
1
Frequently asked questions
Who invested in DreaMed?
DreaMed has 1 investors on record on gritt.io and 1 late-stage investors.
When did DreaMed last raise funding?
The most recent investment in DreaMed recorded on gritt.io was in September 2024.
When was DreaMed founded?
DreaMed was founded in 2014.
What industry is DreaMed in?
DreaMed operates in Hospitals and Health Care. Find similar Hospitals and Health Care investors on gritt.io.
Where is DreaMed based?
DreaMed is headquartered in Petah Tikva, Israel.